{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05067387",
            "orgStudyIdInfo": {
                "id": "21-007289"
            },
            "organization": {
                "fullName": "University of California, Los Angeles",
                "class": "OTHER"
            },
            "briefTitle": "Evaluation of Oral THC and CBD in Men and Women",
            "officialTitle": "Evaluation of Oral THC and CBD in Oral Fluid, Pharmacokinetics, and Subjective and Neurocognitive Effects in Men and Women",
            "acronym": "O-TACOFS",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluation-of-oral-thc-and-cbd-in-men-and-women"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-09-14",
            "studyFirstSubmitQcDate": "2021-09-23",
            "studyFirstPostDateStruct": {
                "date": "2021-10-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-28",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Ziva D. Cooper, PhD",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "University of California, Los Angeles"
            },
            "leadSponsor": {
                "name": "University of California, Los Angeles",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.",
            "detailedDescription": "This double-blind placebo controlled, within-subject study study will assess testing devices that can measure biochemical markers in oral fluid and neurocognitive-performance markers of recent THC or CBD use. Other pharmacodynamic effects of oral THC or CBD will be determined and the pharmacokinetics of THC, CBD, and respective metabolites will be assessed in whole blood."
        },
        "conditionsModule": {
            "conditions": [
                "Drug Abuse",
                "Intoxication by Drug",
                "Impairment"
            ],
            "keywords": [
                "THC",
                "CBD",
                "Intoxication",
                "Impairment"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "This is a randomized, double-blind, placebo-controlled study. All participants will complete all dose conditions in a randomized order.",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 22,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Oral placebo; sesame and MCT oil",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "20 mg THC",
                    "type": "EXPERIMENTAL",
                    "description": "THC suspended in sesame oil",
                    "interventionNames": [
                        "Drug: THC"
                    ]
                },
                {
                    "label": "20 mg CBD",
                    "type": "EXPERIMENTAL",
                    "description": "CBD suspended in MCT oil",
                    "interventionNames": [
                        "Drug: CBD"
                    ]
                },
                {
                    "label": "20 mg THC + 20 mg CBD",
                    "type": "EXPERIMENTAL",
                    "description": "THC and CBD in sesame and MCT oil",
                    "interventionNames": [
                        "Drug: THC + CBD"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Oral placebo",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "THC",
                    "description": "Oral THC (20 mg)",
                    "armGroupLabels": [
                        "20 mg THC"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "CBD",
                    "description": "Oral CBD (20 mg)",
                    "armGroupLabels": [
                        "20 mg CBD"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "THC + CBD",
                    "description": "Oral THC (20 mg) + CBD (20 mg)",
                    "armGroupLabels": [
                        "20 mg THC + 20 mg CBD"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Ratings of subjective drug effects",
                    "description": "Average and peak subjective ratings of drug effects associated with abuse liability as measured using visual analogue scales (VAS; 1-100mm).",
                    "timeFrame": "6 hours"
                },
                {
                    "measure": "Concentration of THC, CBD and metabolites in whole blood",
                    "description": "Peak blood levels of THC, CBD, 11-OH-THC, and THCCOOH as measured in ng/ml",
                    "timeFrame": "6 hours"
                },
                {
                    "measure": "Behavioral task performance as assessed by the DRUID App Score",
                    "description": "Composite score on the DRUID App, a measure of behavioral task performance (range 0-100) where lower scores indicate better performance",
                    "timeFrame": "6 hours"
                },
                {
                    "measure": "Concentration of THC in oral fluid",
                    "description": "Liquid chromatography-tandem mass spectrometry",
                    "timeFrame": "6 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or non-pregnant and non-lactating females aged 21-55 years\n* Report weekly-monthly use of cannabis (\u22641 day per week) over the past month prior to screening,\n* Not currently seeking treatment for their cannabis use\n* Have a Body Mass Index from 18.5 - 34kg/m2.\n* Able to perform all study procedures\n* Must be using a contraceptive (hormonal or barrier methods)\n\nExclusion Criteria:\n\n* Meeting DSM-V criteria for moderate to severe Cannabis Use disorder (CUD) or any substance use disorder other than nicotine, caffeine\n* Any other Axis I disorder\n* Report using other illicit drugs in the prior 4 weeks, other than cannabis.\n* Current use of any medications that may affect study outcomes\n* If medical history, physical and psychiatric examination, or laboratory tests performed during the screening process are not within the normal range and / or reveal any significant illness (e.g., hypertension) as judged by the study physician and to put the participant at greater risk of experiencing adverse events due to completion of study procedures.\n* Pregnancy is exclusionary due to the possible effects of the study medication on fetal development.\n* History of an allergic reaction or adverse reaction to cannabis is exclusionary.\n* History of respiratory illness or current respiratory illness\n* Currently enrolled in another research protocol\n* Not using a contraceptive method (hormonal or barrier methods)\n* The evaluating physician reviews all medical assessments along with medical history. Any disorders that might make cannabis administration hazardous are exclusionary.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ziva Cooper, PhD",
                    "role": "CONTACT",
                    "phone": "310-206-9942",
                    "email": "zcooper@mednet.ucla.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ziva Cooper",
                    "affiliation": "University of California, Los Angeles",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, Los Angeles",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ziva Cooper, PhD",
                            "role": "CONTACT",
                            "phone": "310-206-9942",
                            "email": "zcooper@mednet.ucla.edu"
                        },
                        {
                            "name": "Vince Acebo",
                            "role": "CONTACT",
                            "phone": "310-983-3417",
                            "email": "vacebo@mednet.ucla.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "asFound": "Drug Abuse",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013759",
                    "term": "Dronabinol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006213",
                    "term": "Hallucinogens"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000063386",
                    "term": "Cannabinoid Receptor Agonists"
                },
                {
                    "id": "D000063385",
                    "term": "Cannabinoid Receptor Modulators"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16527",
                    "name": "Dronabinol",
                    "asFound": "1500",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9305",
                    "name": "Hallucinogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}